{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:10:17Z","timestamp":1765890617643,"version":"3.48.0"},"reference-count":87,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"unspecified","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,5,7]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess whether treatment with drugs that activate the Wnt pathway leads to an increased risk of cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review reported using Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) reporting guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>PubMed, Embase and the Cochrane Library were searched through 1 November 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>All primary research articles reporting clinical studies, including observational and experimental studies, were included in this review. All studies were eligible for inclusion if they included the exposure of interest, that is, compounds which have been described to activate the Wnt pathway, and the outcome of interest, that is, cancer prevalence. No language restrictions were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>This study was reported according to the PRISMA reporting guidelines. The search string, objectives, and study protocol methods were defined before the study was initiated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 48 studies investigating drugs that activate the Wnt pathway (valproic acid, lithium, cimetidine, olanzapine, clozapine, haloperidol) were included in this systematic review. The results from this systematic review show that, at least for the included compounds in the currently used systemic dosage, cancer prevalence does not significantly increase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The current study found that the use of drugs that activate the Wnt pathway was not associated with an increased risk of cancer. As a promising agent in the regenerative therapy field, further research into Wnt activation as a treatment option should be explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42021286193.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-103296","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T06:40:51Z","timestamp":1748587251000},"page":"e103296","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer prevalence after exposure to Wnt-activating drugs: a systematic review"],"prefix":"10.1136","volume":"15","author":[{"given":"Ahmed","family":"Alkashaf","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2170-4157","authenticated-orcid":false,"given":"Natalia","family":"Smith-Cortinez","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands"},{"name":"UMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina E","family":"Fenton","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands"},{"name":"UMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian Thomas","family":"Bok","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J","family":"Stokroos","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands"},{"name":"UMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5154-7178","authenticated-orcid":false,"given":"Inge","family":"Stegeman","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands"},{"name":"UMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise V","family":"Straatman","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands"},{"name":"UMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"2025121605060385000_15.5.e103296.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.05.016"},{"key":"2025121605060385000_15.5.e103296.2","doi-asserted-by":"crossref","DOI":"10.1242\/dev.146589","article-title":"Wnt signaling in development and tissue homeostasis","volume":"145","author":"Steinhart","year":"2018","journal-title":"Development"},{"key":"2025121605060385000_15.5.e103296.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4233"},{"key":"2025121605060385000_15.5.e103296.4","doi-asserted-by":"publisher","DOI":"10.1042\/BST20120122"},{"key":"2025121605060385000_15.5.e103296.5","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-012-9417-5"},{"key":"2025121605060385000_15.5.e103296.6","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101063","article-title":"Wnt signaling pathway in aging-related tissue fibrosis and therapies","volume":"60","author":"Hu","year":"2020","journal-title":"Ageing Res Rev"},{"key":"2025121605060385000_15.5.e103296.7","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9392132","article-title":"Emerging role and therapeutic implication of Wnt signaling pathways in autoimmune diseases","volume":"2016","author":"Shi","year":"2016","journal-title":"J Immunol Res"},{"key":"2025121605060385000_15.5.e103296.8","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2389"},{"key":"2025121605060385000_15.5.e103296.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2009.06.016"},{"key":"2025121605060385000_15.5.e103296.10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/pro.2446","article-title":"Structure and function of LGR5: an enigmatic G-protein coupled receptor marking stem cells","volume":"23","author":"Kumar","year":"2014","journal-title":"Protein Sci"},{"key":"2025121605060385000_15.5.e103296.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160414","article-title":"WNT2 promotes cervical carcinoma metastasis and induction of epithelial-mesenchymal transition","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS ONE"},{"key":"2025121605060385000_15.5.e103296.12","doi-asserted-by":"publisher","DOI":"10.1086\/386293"},{"key":"2025121605060385000_15.5.e103296.13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10637-015-0278-7","article-title":"A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin","volume":"33","author":"Gray","year":"2015","journal-title":"Invest New Drugs"},{"key":"2025121605060385000_15.5.e103296.14","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1122781"},{"key":"2025121605060385000_15.5.e103296.15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clineuro.2016.04.021","article-title":"Randomized placebo-controlled trial of sodium valproate in progressive supranuclear palsy","volume":"146","author":"Leclair-Visonneau","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"key":"2025121605060385000_15.5.e103296.16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/JAD-2012-120805","article-title":"Treatment of Alzheimer\u2019s disease with the GSK-3 inhibitor tideglusib: a pilot study","volume":"33","author":"del Ser","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"2025121605060385000_15.5.e103296.17","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12203"},{"key":"2025121605060385000_15.5.e103296.18","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25824"},{"key":"2025121605060385000_15.5.e103296.19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/1346-8138.12422","article-title":"Topical valproic acid increases the hair count in male patients with androgenetic alopecia: a randomized, comparative, clinical feasibility study using phototrichogram analysis","volume":"41","author":"Jo","year":"2014","journal-title":"J Dermatol"},{"key":"2025121605060385000_15.5.e103296.20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/jocd.12225","article-title":"Topical application of the Wnt\/\u03b2-catenin activator methyl vanillate increases hair count and hair mass index in women with androgenetic alopecia","volume":"15","author":"Tosti","year":"2016","journal-title":"J Cosmet Dermatol"},{"key":"2025121605060385000_15.5.e103296.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00307-z"},{"key":"2025121605060385000_15.5.e103296.22","doi-asserted-by":"crossref","DOI":"10.3390\/genes9110522","article-title":"Valproic acid inhibits proliferation and reduces invasiveness in glioma stem cells through WNT\/\u03b2 catenin signalling activation","volume":"9","author":"Riva","year":"2018","journal-title":"Genes (Basel)"},{"key":"2025121605060385000_15.5.e103296.23","doi-asserted-by":"publisher","DOI":"10.1021\/jm7009765"},{"key":"2025121605060385000_15.5.e103296.24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10571-021-01129-9","article-title":"Lithium as a neuroprotective agent for bipolar disorder: an overview","volume":"42","author":"Ochoa","year":"2022","journal-title":"Cell Mol Neurobiol"},{"key":"2025121605060385000_15.5.e103296.25","doi-asserted-by":"publisher","DOI":"10.1006\/dbio.1997.8552"},{"key":"2025121605060385000_15.5.e103296.26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s12031-021-01940-5","article-title":"Molecular insights to the Wnt signaling during alzheimer\u2019s disorder: a potential target for therapeutic interventions","volume":"72","author":"Nagu","year":"2022","journal-title":"J Mol Neurosci"},{"key":"2025121605060385000_15.5.e103296.27","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061427","article-title":"The role of GSK-3 in cancer immunotherapy: GSK-3 inhibitors as a new frontier in cancer treatment","volume":"9","author":"Augello","year":"2020","journal-title":"Cells"},{"key":"2025121605060385000_15.5.e103296.28","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051110","article-title":"Targeting GSK3 and associated signaling pathways involved in cancer","volume":"9","author":"Duda","year":"2020","journal-title":"Cells"},{"key":"2025121605060385000_15.5.e103296.29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pharmthera.2018.11.008","article-title":"Activating Wnt\/\u03b2-catenin signaling pathway for disease therapy: Challenges and opportunities","volume":"196","author":"Huang","year":"2019","journal-title":"Pharmacology & Therapeutics"},{"key":"2025121605060385000_15.5.e103296.30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"key":"2025121605060385000_15.5.e103296.31","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6947-7-16","article-title":"Utilization of the PICO framework to improve searching PubMed for clinical questions","volume":"7","author":"Schardt","year":"2007","journal-title":"BMC Med Inform Decis Mak"},{"key":"2025121605060385000_15.5.e103296.32","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2025121605060385000_15.5.e103296.33","unstructured":"Wells GA , Shea B , O\u2019connel D , et al . Ottawa Hospital Research Institute, Available: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"2025121605060385000_15.5.e103296.34","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291720000161","article-title":"Haematologic malignancies associated with clozapine v. all other antipsychotic agents: a pharmacovigilance study in VigiBase","volume":"51","author":"Chr\u00e9tien","year":"2021","journal-title":"Psychol Med"},{"key":"2025121605060385000_15.5.e103296.35","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-0652"},{"key":"2025121605060385000_15.5.e103296.36","doi-asserted-by":"publisher","DOI":"10.1007\/BF02787342"},{"key":"2025121605060385000_15.5.e103296.37","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/bcp.13661","article-title":"Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study","volume":"84","author":"Potteg\u00e5rd","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"2025121605060385000_15.5.e103296.38","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jaad.2019.05.055","article-title":"Use of antiepileptic drugs and risk of skin cancer: A nationwide case-control study","volume":"82","author":"Kristensen","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025121605060385000_15.5.e103296.39","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s00415-020-10379-4","article-title":"Anti-seizure medication is not associated with an increased risk to develop cancer in epilepsy patients","volume":"268","author":"Stritzelberger","year":"2021","journal-title":"J Neurol"},{"key":"2025121605060385000_15.5.e103296.40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/YIC.0000000000000197","article-title":"No apparent association between bipolar disorder and cancer in a large epidemiological study of outpatients in a managed care population","volume":"33","author":"Kahan","year":"2018","journal-title":"Int Clin Psychopharmacol"},{"key":"2025121605060385000_15.5.e103296.41","doi-asserted-by":"publisher","DOI":"10.1038\/sj.pcan.4501003"},{"key":"2025121605060385000_15.5.e103296.42","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.2"},{"key":"2025121605060385000_15.5.e103296.43","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0646"},{"key":"2025121605060385000_15.5.e103296.44","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.annepidem.2006.03.003","article-title":"Cimetidine use and the risk for prostate cancer: results from the VITAL cohort study","volume":"16","author":"Velicer","year":"2006","journal-title":"Ann Epidemiol"},{"key":"2025121605060385000_15.5.e103296.45","unstructured":"Rossing MA , Scholes D , Cushing-Haugen KL , et al . Cimetidine use and risk of prostate and breast cancer, Available: http:\/\/aacrjournals.org\/cebp\/article-pdf\/9\/3\/319\/3256582\/ce030000319p.pdf"},{"key":"2025121605060385000_15.5.e103296.46","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.12.1147"},{"key":"2025121605060385000_15.5.e103296.47","doi-asserted-by":"crossref","DOI":"10.7812\/TPP\/18.313","article-title":"Haloperidol and prostate cancer prevention: more epidemiologic research needed","volume":"24","author":"Friedman","year":"2020","journal-title":"Perm J"},{"key":"2025121605060385000_15.5.e103296.48","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1002\/cam4.2329","article-title":"Antipsychotic use is inversely associated with gastric cancer risk: A nationwide population-based nested case-control study","volume":"8","author":"Hsieh","year":"2019","journal-title":"Cancer Med"},{"key":"2025121605060385000_15.5.e103296.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.04.007"},{"key":"2025121605060385000_15.5.e103296.50","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.809014","article-title":"Epigenetics-associated risk reduction of hematologic neoplasms in a nationwide cohort study: the chemopreventive and therapeutic efficacy of hydralazine","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"2025121605060385000_15.5.e103296.51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2011.01607.x"},{"key":"2025121605060385000_15.5.e103296.52","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.116.181362"},{"key":"2025121605060385000_15.5.e103296.53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2018.02.047","article-title":"Long-term use of valproic acid and the prevalence of cancers in bipolar disorder patients in a Taiwanese population: An association analysis using the National Health Insurance Research Database (NHIRD)","volume":"232","author":"Lin","year":"2018","journal-title":"J Affect Disord"},{"key":"2025121605060385000_15.5.e103296.54","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28479"},{"key":"2025121605060385000_15.5.e103296.55","first-page":"637","article-title":"Antiepileptic drugs with histone deacetylase inhibition activity and prostate cancer risk: a population-based case-control study","volume":"27","author":"Salminen","year":"2016","journal-title":"Cancer Causes Control"},{"key":"2025121605060385000_15.5.e103296.56","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9527920","article-title":"Use of antiepileptic drugs and risk of prostate cancer: a nationwide case-control study in prostate cancer data base Sweden","volume":"2023","author":"George","year":"2023","journal-title":"J Oncol"},{"key":"2025121605060385000_15.5.e103296.57","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00406-024-01798-9","article-title":"Exposure to psychotropic drugs and breast cancer risk in patients with bipolar disorder and major depressive disorder: a nested case-control study","volume":"275","author":"Li","year":"2025","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2025121605060385000_15.5.e103296.58","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-0776"},{"key":"2025121605060385000_15.5.e103296.59","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.jid.2017.06.002","article-title":"Association between lithium use and melanoma risk and mortality: a population-based study","volume":"137","author":"Asgari","year":"2017","journal-title":"J Invest Dermatol"},{"key":"2025121605060385000_15.5.e103296.60","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/bdi.12344","article-title":"Lithium and renal and upper urinary tract tumors \u2013 results from a nationwide population\u2010based study","volume":"17","author":"Kessing","year":"2015","journal-title":"Bipolar Disord"},{"key":"2025121605060385000_15.5.e103296.61","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12361"},{"key":"2025121605060385000_15.5.e103296.62","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.euroneuro.2024.04.009","article-title":"Lithium versus anticonvulsants and the risk of physical disorders - Results from a comprehensive long-term nation-wide population-based study emulating a target trial","volume":"84","author":"Kessing","year":"2024","journal-title":"Eur Neuropsychopharmacol"},{"key":"2025121605060385000_15.5.e103296.63","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015010061"},{"key":"2025121605060385000_15.5.e103296.64","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/bjc.2016.10","article-title":"Long-term use of lithium and risk of colorectal adenocarcinoma: a nationwide case-control study","volume":"114","author":"Potteg\u00e5rd","year":"2016","journal-title":"Br J Cancer"},{"key":"2025121605060385000_15.5.e103296.65","doi-asserted-by":"publisher","DOI":"10.1136\/gut.30.11.1558"},{"key":"2025121605060385000_15.5.e103296.66","unstructured":"Rossing MA , Scholes D , Cushing-Haugen KL , et al . Cimetidine use and risk of prostate and breast cancer, 2000. Available: http:\/\/aacrjournals.org\/cebp\/article-pdf\/9\/3\/319\/3256582\/ce030000319p.pdf"},{"key":"2025121605060385000_15.5.e103296.67","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1158\/1055-9965.EPI-04-0547","article-title":"Cimetidine and other histamine2-receptor antagonist use in relation to risk of breast cancer","volume":"14","author":"Coogan","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025121605060385000_15.5.e103296.68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00042560-199707010-00005","article-title":"Non-Hodgkin\u2019s lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area: allergies, prior medication use, and sexual practices","volume":"15","author":"Holly","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"2025121605060385000_15.5.e103296.69","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00001648-199005000-00012","article-title":"Cimetidine use and gastric cancer","volume":"1","author":"Schumacher","year":"1990","journal-title":"Epidemiology (Sunnyvale)"},{"key":"2025121605060385000_15.5.e103296.70","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.9.1166"},{"key":"2025121605060385000_15.5.e103296.71","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-0765"},{"key":"2025121605060385000_15.5.e103296.72","first-page":"13","article-title":"Post-cimetidine surveillance for up to ten years: incidence of carcinoma of the stomach and oesophagus","volume":"78","author":"Colin-Jones","year":"1991","journal-title":"Q J Med"},{"key":"2025121605060385000_15.5.e103296.73","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6379.1713"},{"key":"2025121605060385000_15.5.e103296.74","doi-asserted-by":"crossref","first-page":"526","DOI":"10.9758\/cpn.2022.20.3.526","article-title":"Haloperidol and other antipsychotics exposure before endometrial cancer diagnosis: a population-based case-control study","volume":"20","author":"Chen","year":"2022","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"2025121605060385000_15.5.e103296.75","doi-asserted-by":"crossref","DOI":"10.1186\/s40780-021-00199-7","article-title":"Effect of antipsychotics on breast tumors by analysis of the Japanese Adverse Drug Event Report database and cell-based experiments","volume":"7","author":"Maeshima","year":"2021","journal-title":"J Pharm Health Care Sci"},{"key":"2025121605060385000_15.5.e103296.76","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/YIC.0000000000000247","article-title":"Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance)","volume":"34","author":"Lertxundi","year":"2019","journal-title":"Int Clin Psychopharmacol"},{"key":"2025121605060385000_15.5.e103296.77","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.6.748"},{"key":"2025121605060385000_15.5.e103296.78","doi-asserted-by":"publisher","DOI":"10.1016\/s2215-0366(22)00044-x"},{"key":"2025121605060385000_15.5.e103296.79","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.23m15149","article-title":"Association between clozapine exposure and risk of hematologic malignancies in veterans with schizophrenia","volume":"85","author":"Brainerd","year":"2024","journal-title":"J Clin Psychiatry"},{"key":"2025121605060385000_15.5.e103296.80","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0000000000001699"},{"key":"2025121605060385000_15.5.e103296.81","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40801-024-00417-2","article-title":"Relationship between clozapine and non-hematological malignant tumors: a pharmacovigilance analysis using the FDA adverse event reporting system database","volume":"11","author":"Uwai","year":"2024","journal-title":"Drugs Real World Outcomes"},{"key":"2025121605060385000_15.5.e103296.82","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/cam4.680","article-title":"Long-term risk of gastrointestinal cancers in persons with gastric or duodenal ulcers","volume":"5","author":"S\u00f8gaard","year":"2016","journal-title":"Cancer Med"},{"key":"2025121605060385000_15.5.e103296.83","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/pgs-2018-0188","article-title":"Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective","volume":"20","author":"Legge","year":"2019","journal-title":"Pharmacogenomics"},{"key":"2025121605060385000_15.5.e103296.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2006.06.006"},{"key":"2025121605060385000_15.5.e103296.85","doi-asserted-by":"crossref","first-page":"22811","DOI":"10.18632\/oncotarget.15206","article-title":"Biological basis and clinical study of glycogen synthase kinase- 3\u03b2-targeted therapy by drug repositioning for glioblastoma","volume":"8","author":"Furuta","year":"2017","journal-title":"Oncotarget"},{"key":"2025121605060385000_15.5.e103296.86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.04527.x"},{"key":"2025121605060385000_15.5.e103296.87","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2019.06.038","article-title":"Wnt activator CHIR99021-stimulated human dermal papilla spheroids contribute to hair follicle formation and production of reconstituted follicle-enriched human skin","volume":"516","author":"Yoshida","year":"2019","journal-title":"Biochem Biophys Res Commun"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-103296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:06:16Z","timestamp":1765890376000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-103296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":87,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,30]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bmjopen-2025-103296"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-103296","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}